Drug
Tecovirimat clinical trials
Also written TPOXX and ST-246.
- studies test it
- 14
- open now
- 1
- in phase 3
- 5
- first study started
- 2006
Keep track of what changes. Save the tecovirimat studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2022 (5)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 3
- Phase 3
- 5
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 6
SIGA Technologies (8) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · ANRS, Emerging Infectious Diseases (1) · Miquel Ekkelenkamp (1) · Marina Klein (1)
Often tested with
Tested in the same studies.
Smallpox Vaccine (1)
Studies
Open first, then newest update. How each study uses tecovirimat is read from its arms, and is right about nine times in ten.
Testing it · 14
- European Trial Into Mpox InfectionRecruitingPhase 4Miquel EkkelenkampNCT06156566Written as Tecovirimat Oral Capsule
- Phase I Trial of an Investigational Small Pox MedicationCompletedPhase 1SIGA TechnologiesNCT00728689Written as ST-246 Days 1 - 3
- Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy VolunteersCompletedPhase 1SIGA TechnologiesNCT00431951Written as ST-246
- Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOSActive, not recruitingPhase 2SIGA TechnologiesNCT04957485Written as Tecovirimat
- A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound TecovirimatCompletedPhase 3SIGA TechnologiesNCT02474589Written as tecovirimat
- Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KGCompletedPhase 4SIGA TechnologiesNCT04392739Written as Tpoxx
- Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246CompletedPhase 2SIGA TechnologiesNCT00907803Written as ST-246 400 mg
- Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate BindersCompletedPhase 4SIGA TechnologiesNCT04485039Written as Tecovirimat
- Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 DaysCompletedPhase 3SIGA TechnologiesNCT04971109Written as TPOXX
- Study of Tecovirimat for Human Mpox VirusTerminatedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT05534984Written as Tecovirimat Oral Capsule
- Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus DiseaseActive, not recruitingPhase 3ANRS, Emerging Infectious DiseasesNCT05597735Written as Tecovirimat
- Tecovirimat in Non-hospitalized Patients With MonkeypoxSuspendedPhase 3Marina KleinNCT05534165Written as Tecovirimat
- Tecovirimat for Treatment of Monkeypox VirusCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT05559099Written as Tecovirimat Oral Capsule
- SIGA-246 to Treat SmallpoxWithdrawnPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00303225Written as Vaccine: SIGA-246
Codes
What other systems call tecovirimat · ClinicalTrials.gg INT004830
- MeSH (NLM) C505045tecovirimatConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) F925RR824RTECOVIRIMATConfirmed FDA, NLM, Wikidata
- RxNorm 2055104One source FDA
- Wikidata Q7692792tecovirimatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81606TecovirimatOne source FDA
- DrugBank DB12020One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C505045 | tecovirimat | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | F925RR824R | TECOVIRIMAT | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2055104 | — | One source FDA |
| Wikidata | Q7692792 | tecovirimat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81606 | Tecovirimat | One source FDA |
| DrugBank | DB12020 | — | One source Wikidata |
Also registered as tecovirimat monohydrate (UNII SB96YO2BR8 · RxNorm 2055103).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.